732298-45-2Relevant articles and documents
Novel N-biphenyl-2-ylmethyl 2-methoxyphenylpiperazinylalkanamides as 5-HT7R antagonists for the treatment of depression
Kim, Youngjae,Tae, Jinsung,Lee, Kangho,Rhim, Hyewhon,Choo, Il Han,Cho, Heeyeong,Park, Woo-Kyu,Keum, Gyochang,Choo, Hyunah
, p. 4587 - 4596 (2014/10/15)
5-HT7 receptor (5-HT7R) is a promising target for the treatment of depression and neuropathic pain. 5-HT7R antagonists exhibited antidepressant effects, while the agonists produced strong anti-hyperalgesic effects. In our efforts to discover selective 5-HT 7R antagonists or agonists, N-biphenylylmethyl 2- methoxyphenylpiperazinylalkanamides 1 were designed, synthesized, and biologically evaluated against 5-HT7R. Among the synthesized compounds, N-2′-chlorobiphenylylmethyl 2- methoxyphenylpiperazinylpentanamide 1-8 showed the best binding affinity with a Ki value of 8.69 nM and it was verified as a novel antagonist according to functional assays. The compound 1-8 was very selective over 5-HT1DR, 5-HT2AR, 5-HT3R, 5-HT5AR and 5-HT6R and moderately selective over 5-HT1AR, 5-HT1BR and 5-HT2CR. The novel 5-HT7R antagonist 1-8 exhibited an antidepressant effect at a dose of 25 mg/kg in the forced swimming test in mice and showed a U-shaped dose-response curve which typically appears in 5-HT7R antagonists such as SB-269970 and lurasidone.
Novel quinazolinone derivatives as 5-HT7 receptor ligands
Na, Yong Ho,Hong, Sung Ho,Lee, Jung Hyang,Park, Woo-Kyu,Baek, Du-Jong,Koh, Hun Yeong,Cho, Yong Seo,Choo, Hyunah,Pae, Ae Nim
, p. 2570 - 2578 (2008/09/21)
5-HT7 receptor antagonists generated antidepressant-like effects in animal model and the involvement of the 5-HT7 receptor in other pathophysiological mechanisms such as thermoregulation, learning and memory, and sleep has been highl